Package Leaflet: Information for the User
Cadelius D 600 mg/2,000 IU Oral Dispersible Tablets
calcium / colecalciferol
This medicine is used to treat calcium and vitamin D deficiency in adults.
This medicine contains calcium and vitamin D3, both of which are important for bone formation. Vitamin D3 regulates the absorption and metabolism of calcium, as well as the incorporation of calcium into bones.
Ask your doctor or pharmacist if you have any questions and always follow their instructions.
You should consult a doctor if your condition worsens or does not improve within a few days.
|
Consult your doctor or pharmacist before starting to take Cadelius D 600 mg/2,000 IU.
Children and adolescents
The use of Cadelius D 600mg/2,000 IU is not recommended in children or adolescents.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
The effect of treatment may be affected if this medicine is taken at the same time as other medicines used for:
Please make sure your doctor knows if you are taking any of the medicines listed above. Your dose may need to be changed.
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
The absorption of calcium may be inhibited by foods containing oxalic acid (present in spinach and rhubarb) or phytic acid (present in most cereals). It is recommended not to take this medicine during the 2 hours following the intake of foods with high content of oxalic acid or phytic acid.
This medicine is not recommended during pregnancy.
Cadelius D 600 mg/2,000 IU can be taken during breastfeeding. Calcium and vitamin D3 pass into breast milk. This should be taken into account when administering additional vitamin D to the baby. Supplementation with Cadelius D 600 mg/2,000 IU does not replace the administration of vitamin D in newborns.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and using machines:
No effects on the ability to drive and use machines have been observed.
Cadelius D 600 mg/2,000 IU contains aspartame, lactose, sucrose, and partially hydrogenated soybean oil
This medicine contains 8.67 mg of aspartame in each tablet.
Aspartame is a source of phenylalanine, which may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates due to the body's inability to eliminate it properly.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine. It may cause tooth decay.
This medicine contains soybean oil. It should not be used in case of peanut or soy allergy.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is established by your doctor for you individually.
The usual dose is: 1 tablet per day.
The tablets should be dissolved in the mouth. They should not be swallowed whole.
The tablets should be taken preferably after meals.
The amount of calcium in Cadelius D 600 mg/2,000 IU is less than the daily recommended intake. Therefore, this medicine is recommended for patients who need an additional intake of vitamin D but have a daily intake of 500-1,000 mg of calcium per day. Your doctor should estimate the amount of your daily calcium intake through diet.
Use in children and adolescents
Cadelius D 600 mg/2,000 IU is not indicated in children and adolescents.
Call your doctor or pharmacist immediately if you take more of this medicine than prescribed by your doctor. You can also contact the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
The symptoms of a possible overdose of Cadelius D 600 mg/2,000 IU may include loss of appetite, thirst, abnormal emission of large amounts of urine, nausea, vomiting, and constipation.
Do not take a double dose to make up for forgotten doses.
Take it as soon as you remember. Then take the next dose as usual. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine and inform your doctor immediately if you experience symptoms of serious allergic reactions such as:
Uncommon side effects (may affect up to 1 in 100 people):hypercalcemia (elevated levels of calcium in the blood) and/or hypercalciuria (elevated levels of calcium in the urine).
Rare side effects (may affect less than 1 in 1,000 people):constipation, flatulence, nausea, abdominal distension (pain), diarrhea, pruritus (itching), rash, and hives.
Unknown frequency side effects (cannot be estimated from the available data):serious allergic reactions.
Other special populations
Patients with renal insufficiency may have a potential risk of hyperphosphatemia, nephrolithiasis, and nephrocalcinosis.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency's Pharmacovigilance System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Medicines should not be disposed of via wastewater or household waste. Place the container and any unused medicine in the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to dispose of the container and any unused medicine. This will help protect the environment.
The active ingredients are calcium carbonate 1,500 mg, corresponding to 600 mg of calcium, and colecalciferol 2,000 IU (vitamin D3) corresponding to 0.050 mg.
The other ingredients are: maltodextrin, anhydrous citric acid (E330), low-substituted hydroxypropylcellulose (E463), lactose monohydrate, stearic acid, aspartame (E951), sucrose, gelatin, orange flavor (natural flavorings, maltodextrin, dextrin), corn starch, partially hydrogenated soybean oil, all-rac-α-tocopherol (E 307), silicon dioxide.
White or almost white, circular, beveled oral dispersible tablets.
Bottle of 30 tablets.
Multi-pack of 60 (2 bottles of 30) oral dispersible tablets.
Not all pack sizes may be marketed.
Marketing authorization holder:
ITALFARMACO, S.A.
San Rafael, 3 – 28108 Alcobendas (Madrid), SPAIN
Tel.: 916572323
Manufacturer:
ITALFARMACO, S.p.A.
Viale Fulvio Testi 330
Milan (ITALY)
Tel.: 39 02 6443.1
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Especialidades Farmacéuticas Centrum, S.A.
C/ Sagitario 14
03006 Alicante
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Spain: Cadelius 600 mg/2,000 IU oral dispersible tablets
Italy: Riliscal 600 mg/2000 U.I. compresse orodispersibili
Portugal: Riliscal 600 mg/2000 IU comprimidos orodispersíveis
Greece: CADELIUS 600 mg + 2,000 IU δισκ?α διασπειρ?μενα στο στ?μα
Date of last revision of this leaflet: June 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The average price of CADELIUS D 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS in October, 2025 is around 18.01 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.